Skip to main content
. 2022 Nov 9;14(1):52–60. doi: 10.1111/1759-7714.14711

FIGURE 1.

FIGURE 1

Consolidated standards of reporting trials (CONSORT) diagram. DPP4 i, DPP4 inhibitor; ICI, immune checkpoint inhibitor; LCNEC, large cell neuroendocrine carcinoma; NSCLC, non‐small cell lung cancer; SCLC, small cell lung cancer.